BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 22539245)

  • 1. Difficult differential diagnosis of Unverricht-Lundborg disease with spontaneous kinesogenic myoclonus and movement disorder.
    Rana AQ; Ali A; Böke BN
    Acta Neurol Belg; 2012 Dec; 112(4):383-4. PubMed ID: 22539245
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical picture of EPM1-Unverricht-Lundborg disease.
    Kälviäinen R; Khyuppenen J; Koskenkorva P; Eriksson K; Vanninen R; Mervaala E
    Epilepsia; 2008 Apr; 49(4):549-56. PubMed ID: 18325013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Unverricht-Lundborg disease].
    Naito H; Wachi M
    Ryoikibetsu Shokogun Shirizu; 2002; (37 Pt 6):189-93. PubMed ID: 12483858
    [No Abstract]   [Full Text] [Related]  

  • 4. First Molecular Diagnosis of a Patient with Unverricht-Lundborg Disease in Korea.
    Kim KH; Song JS; Park CW; Ki CS; Heo K
    Yonsei Med J; 2018 Aug; 59(6):798-800. PubMed ID: 29978618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimyoclonic effect of levetiracetam in 13 patients with Unverricht-Lundborg disease: clinical observations.
    Magaudda A; Gelisse P; Genton P
    Epilepsia; 2004 Jun; 45(6):678-81. PubMed ID: 15144434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of efficacy and potential aggravation of myoclonus with lamotrigine in Unverricht-Lundborg disease.
    Genton P; Gelisse P; Crespel A
    Epilepsia; 2006 Dec; 47(12):2083-5. PubMed ID: 17201707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variable course of Unverricht-Lundborg disease: Early prognostic factors.
    Canafoglia L; Ferlazzo E; Michelucci R; Striano P; Magaudda A; Gambardella A; Pasini E; Belcastro V; Riguzzi P; Fanella M; Granata T; Beccaria F; Trentini C; Bianchi A; Aguglia U; Panzica F; Franceschetti S
    Neurology; 2017 Oct; 89(16):1691-1697. PubMed ID: 28931642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pilot open-label trial of zonisamide in Unverricht-Lundborg disease.
    Italiano D; Pezzella M; Coppola A; Magaudda A; Ferlazzo E; Bramanti P; Striano S; Zara F; Striano P
    Mov Disord; 2011 Feb; 26(2):341-3. PubMed ID: 20939070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T2-weighted high-intensity signals in the basal ganglia as an interesting image finding in Unverricht-Lundborg disease.
    Korja M; Ferlazzo E; Soilu-Hänninen M; Magaudda A; Marttila R; Genton P; Parkkola R
    Epilepsy Res; 2010 Jan; 88(1):87-91. PubMed ID: 19896804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unverricht-Lundborg disease: Clinical course and seizure management based on the experience of polish centers.
    Lasek-Bal A; Lukasik M; Żak A; Sulek A; Bosak M
    Seizure; 2019 Jul; 69():87-91. PubMed ID: 30999254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The natural history of Unverricht-Lundborg disease: a report of eight genetically proven cases.
    Chew NK; Mir P; Edwards MJ; Cordivari C; Martino D; Schneider SA; Kim HT; Quinn NP; Bhatia KP
    Mov Disord; 2008 Jan; 23(1):107-13. PubMed ID: 17994572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unverricht-Lundborg progressive myoclonus epilepsy in Oman.
    Santoshkumar B; Turnbull J; Minassian BA
    Pediatr Neurol; 2008 Apr; 38(4):252-5. PubMed ID: 18358403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Movement-related desynchronization-synchronization (ERD/ERS) in patients with Unverricht-Lundborg disease.
    Visani E; Agazzi P; Canafoglia L; Panzica F; Ciano C; Scaioli V; Avanzini G; Franceschetti S
    Neuroimage; 2006 Oct; 33(1):161-8. PubMed ID: 16904345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Marked response to perampanel: A decade-long course of giant somatosensory evoked potentials in Unverricht-Lundborg disease.
    Tojima M; Takahashi R; Neshige S; Hitomi T; Matsuhashi M; Ikeda A
    Clin Neurophysiol; 2021 Oct; 132(10):2329-2331. PubMed ID: 34454258
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-term evolution of EEG in Unverricht-Lundborg disease.
    Gargouri-Berrechid A; Nasri A; Kacem I; Sidhom Y; Abdelkefi I; Hizem Y; Ben Djebrara M; Gouider R
    Neurophysiol Clin; 2016 Apr; 46(2):119-24. PubMed ID: 27157382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Low-dose perampanel improved cortical myoclonus and basophobia in a patient with Unverricht-Lundborg disease: a case report].
    Oi Y; Kobayashi K; Hitomi T; Matsumoto R; Ikeda A; Takahashi R
    Rinsho Shinkeigaku; 2018 Oct; 58(10):622-625. PubMed ID: 30270337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Unverricht-Lundborg disease manifesting tremulous myoclonus with rare convulsive seizures: a case report].
    Kondo T; Yamakado H; Kawamata J; Tomimoto H; Hitomi T; Takahashi R; Ikeda A
    Rinsho Shinkeigaku; 2009 Jan; 49(1):43-7. PubMed ID: 19227896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ropinirole diminishes myoclonus and improves writing and postural balance in an ULD patient.
    Karvonen MK; Kaasinen V; Korja M; Marttila RJ
    Mov Disord; 2010 Mar; 25(4):520-1. PubMed ID: 20155865
    [No Abstract]   [Full Text] [Related]  

  • 19. Perampanel in 12 patients with Unverricht-Lundborg disease.
    Crespel A; Gelisse P; Tang NP; Genton P
    Epilepsia; 2017 Apr; 58(4):543-547. PubMed ID: 28166365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unverricht-Lundborg disease with cystatin B gene abnormalities.
    Kagitani-Shimono K; Imai K; Okamoto N; Ono J; Okada S
    Pediatr Neurol; 2002 Jan; 26(1):55-60. PubMed ID: 11814737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.